November 15, 2023
Clinical Research News highlighted recommendations to improve recruitment in acute stroke trials, led by UC's Joseph Broderick, following the Stroke Treatment Academic Industry Roundtable XII earlier this year.
November 7, 2023
The University of Cincinnati Cancer Center’s Vladimir Bogdanov found a new drug developed in his lab was effective at preventing pancreatic cancer growth and spread when combined with chemotherapy in lab tests.
November 28, 2023
The University of Cincinnati Cancer Center's Robert Van Haren joined the Research Evangelist podcast to discuss advancements in lung cancer care and research to improve accessibility to treatments.
November 27, 2023
The University of Cincinnati Cancer Center's Andrew Frankart, MD, is leading a new clinical trial that will test the safety and effectiveness of a more targeted radiation dose for patients with large tumors.
November 27, 2023
Local 12 recently spoke with the University of Cincinnati's Andrew Waters and Pancreatic Cancer Action Network volunteers to discuss ongoing pancreatic cancer research and funding support during Pancreatic Cancer Awareness Month.
November 13, 2023
A new clinical trial underway at the UC Gardner Neuroscience Institute is applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
December 8, 2023
University of Cincinnati Cancer Center researchers will present abstracts at the American Society of Hematology Annual Meeting, held Dec. 9-12 in San Diego, California.
December 8, 2023
The University of Cincinnati's Pooja Khatri and Eva Mistry spoke with Local 12 about the SISTER trial that will test a new drug to treat patients with strokes who are not eligible to receive traditional treatments due to timing factors or risk of complications.
December 7, 2023
The UC Gardner Neuroscience Institute has received $19 million in federal funding from the National Institutes of Health to serve as the lead center for a Phase 2 clinical trial that will study the efficacy of a new monoclonal antibody treatment for patients ineligible for currently available treatments.
February 7, 2024
University of Cincinnati neurology experts are presenting research at the International Stroke Conference 2024, Feb. 7-9 in Phoenix, Arizona.